Piramal Pharma Adjusts Evaluation Score Amidst Debt Challenges and Growth Potential

Sep 04 2025 08:22 AM IST
share
Share Via
Piramal Pharma has recently adjusted its evaluation score, reflecting a change in technical trends. The company has shown a 4.28% return over the past year and a 32.9% increase in profits, despite facing challenges such as a high Debt to EBITDA ratio and limited profitability.
Piramal Pharma, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a bearish stance to a mildly bearish outlook.

The company's current price stands at 201.20, with a previous close of 186.80. Over the past year, Piramal Pharma has generated a return of 4.28%, while its profits have increased by 32.9%. However, the company faces challenges, including a high Debt to EBITDA ratio of 3.21 times, indicating potential difficulties in servicing its debt. Additionally, the Return on Equity has averaged only 0.87%, suggesting limited profitability relative to shareholders' funds.

Despite these hurdles, Piramal Pharma has demonstrated healthy long-term growth, with an operating profit growth rate of 31.99%. The stock is currently trading at a discount compared to its peers' average historical valuations, and it boasts a significant institutional holding of 45.12%, which may provide a buffer against market volatility.

For more insights on Piramal Pharma's financial trends, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News